ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 41 | October 25, 1985

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

January 17, 2003

In Brief: Rhode Island, Los Angeles Approved For NCI Community Implementation Awards; Hawaii Close

July 8, 1977

John Durant Names ASCO Executive NP; A New Position, New Voice In Washington

December 2, 1994

DCPC Board Will Consider Revised Concepts For CPRUs

September 18, 1987

NCI Posts Website Usability Research, Information Online.

January 12, 2001

Tamoxifen Makes ER-Negative Breast Cancer Easier To Find

October 31, 2008